Home/Filings/4/0000950170-24-013269
4//SEC Filing

Yoskowitz Marc J 4

Accession 0000950170-24-013269

CIK 0001719714other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:15 PM ET

Size

8.0 KB

Accession

0000950170-24-013269

Insider Transaction Report

Form 4
Period: 2024-02-08
Transactions
  • Award

    Deferred Restricted Stock Units

    2024-02-08+14,13914,139 total
    American Depository Shares (14,139 underlying)
  • Award

    Share Options (Right to buy)

    2024-02-08+45,00045,000 total
    Exercise: $3.87Exp: 2034-02-08American Depository Shares (45,000 underlying)
Footnotes (3)
  • [F1]Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date.
  • [F2]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
  • [F3]Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

Documents

1 file

Issuer

Mereo BioPharma Group plc

CIK 0001719714

Entity typeother

Related Parties

1
  • filerCIK 0001617306

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:15 PM ET
Size
8.0 KB